Bioceltix SA
No trades
−3.0 PLN
−14.90 M PLN
0.00 PLN
5.06 M
About Bioceltix SA
Sector
Industry
CEO
Lukasz Piotr Bzdzion
Website
Headquarters
Wroclaw
Founded
2018
IPO date
Nov 8, 2021
Identifiers
2
ISIN PLBCLTX00019
Bioceltix SA engages in the research and development in the area of veterinary medicine. It develops stem cell therapy for animal use. The company was founded on August 13, 2018 and is headquartered in Wroclaw, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ETFBS80TR
Beta ETF sWIG80TR Portfelowy Fundusz Inwestycyjny Zamkniety UnitsWeight
1.03%
Market value
786.07 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of BCX is 83.6 PLN — it has decreased by −0.71% in the past 24 hours. Watch Bioceltix SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Bioceltix SA stocks are traded under the ticker BCX.
BCX stock has risen by 2.58% compared to the previous week, the month change is a 4.24% rise, over the last year Bioceltix SA has showed a −3.24% decrease.
We've gathered analysts' opinions on Bioceltix SA future price: according to them, BCX price has a max estimate of 133.00 PLN and a min estimate of 133.00 PLN. Watch BCX chart and read a more detailed Bioceltix SA stock forecast: see what analysts think of Bioceltix SA and suggest that you do with its stocks.
BCX stock is 2.18% volatile and has beta coefficient of 0.08. Track Bioceltix SA stock price on the chart and check out the list of the most volatile stocks — is Bioceltix SA there?
Today Bioceltix SA has the market capitalization of 462.50 M, it has decreased by −0.25% over the last week.
Yes, you can track Bioceltix SA financials in yearly and quarterly reports right on TradingView.
BCX net income for the last quarter is −4.38 M PLN, while the quarter before that showed −3.74 M PLN of net income which accounts for −17.33% change. Track more Bioceltix SA financial stats to get the full picture.
No, BCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 8, 2026, the company has 32 employees. See our rating of the largest employees — is Bioceltix SA on this list?
Like other stocks, BCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioceltix SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioceltix SA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioceltix SA stock shows the neutral signal. See more of Bioceltix SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.